Minimal change nephrotic syndrome due to certolizumab pegol, an anti-tumor necrosis factor-alpha monoclonal antibody for treatment of rheumatoid arthritis
RHEUMATOLOGY ADVANCES IN PRACTICE(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
RHEUMATOLOGY ADVANCES IN PRACTICE(2022)